Bank of China Limited (601988.SS) vs AbbVie Inc. (ABBV)
See how Bank of China Limited and AbbVie Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$1.11
Shanghai
Bank of China Limited is one of China’s largest commercial banks and has one of the country’s strongest international banking networks. It provides corporate banking, personal banking, trade finance, foreign exchange, wealth management, and treasury services. The bank has a long history in cross-border finance and serves Chinese companies, global corporates, governments, and retail clients. Its performance is influenced by Chinese economic growth, international trade, interest-rate spreads, credit quality, currency activity, and government policy.
View Full Page$294.55
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full PageKey Metrics Comparison
Bank of China Limited601988.SS
Market Cap$356.284B
Price$1.11
24h Change+0.68%
24h Volume$227.7M
Employees313,746
Shares OutstandingN/A
AbbVie Inc.ABBV
Market Cap$520.651B
Price$294.55
24h Change-0.16%
24h Volume$4.71M
Employees57,000
Shares Outstanding1,768,169,012
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
601988.SS
40.6%ABBV
59.4%Volume Share
Share of combined 24h volume
601988.SS
98.0%ABBV
2.0%24h Performance
Price change over last 24 hours
601988.SS
0.68%ABBV
-0.16%Price Comparison
Bank of China Limited
AbbVie Inc.